Palvella Therapeutics, Inc. Share Price
PVLA$0.00
+0.00 (0.00%) Palvella Therapeutics, Inc. Stock Performance
Open N/A | Prev. Close N/A | Circuit Range N/A |
Day Range N/A | Year Range N/A | Volume N/A |
Average Traded N/A |
Palvella Therapeutics, Inc. Share Price Chart
$0.00
Please wait...
About Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. The company's lead product candidate is QTORIN 3.9% rapamycin anhydrous gel that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformations. It also develops QTORIN rapamycin for the treatment of other mTOR-driven skin diseases. The company is based in Wayne, Pennsylvania
Palvella Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|
FAQs on Palvella Therapeutics, Inc. Share Price
Can I buy Palvella Therapeutics, Inc. shares in India?
Yes. You can buy Palvella Therapeutics, Inc. in India by opening an international trading account.
What is the share price of Palvella Therapeutics, Inc.?
As on 21 Mar '26, the share price of Palvella Therapeutics, Inc. PVLA is $0.00. If you are investing from India, it is a good idea to check the current exchange rate and calculate the value in rupees before making your investment.
What is the 5 year returns of Palvella Therapeutics, Inc.?
The 5 year returns of Palvella Therapeutics, Inc. is as on 21 Mar '26.
What are the high & low stock price of Palvella Therapeutics, Inc. today?
Palvella Therapeutics, Inc. stock price hit a high of $0.00 and low of $0.00 as on 21 Mar '26.
What is the 52-week high and low of Palvella Therapeutics, Inc. stock?
The 52-week high of Palvella Therapeutics, Inc. stock is $0.00, while the 52-week low is $0.00 as on 21 Mar '26.